Evidence map›Paper›PMID 23753411›Full record

ArticleHypertension (Dallas, Tex. : 1979)2013

Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazide.

Stephen T Turner, Eric Boerwinkle, Jeffrey R O'Connell, Kent R Bailey, Yan Gong, Arlene B Chapman, Caitrin W McDonough, Amber L Beitelshees, Gary L Schwartz, John G Gums and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 4 pooled it
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 4 syntheses or guidelines pooled it, 108 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Preliminary Application of Antihypertensive Gene Detection in the Treatment of Hypertension.Medical science monitor : international medical journal of experimental and clinical research · 2026
    Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Circulating microRNA Biomarkers of Thiazide Response in Hypertension.Journal of the American Heart Association · 2024
    Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 2 institutions in 2 countries.

Stephen T TurnerDivision of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA. turner.stephen@mayo.edu
Eric Boerwinkle
Jeffrey R O'Connell
Kent R Bailey
Yan Gong
Arlene B Chapman
Caitrin W McDonough
Amber L Beitelshees
Gary L Schwartz
John G Gums
Sandosh Padmanabhan
Timo P Hiltunen
Lorena Citterio
Kati M Donner
Thomas Hedner
Chiara Lanzani
Olle Melander
Janna Saarela
Samuli Ripatti
Björn Wahlstrand
Paolo Manunta
Kimmo Kontula
Anna F Dominiczak
Rhonda M Cooper-DeHoff
Julie A Johnson
Lund University · SEUniversity of Helsinki · FI

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Pharmacogenomic Evaluation of Antihypertensive ResponsesU01GM074492 · NIGMS · UNIVERSITY OF FLORIDA · PI COOPER-DEHOFF, RHONDA M, JOHNSON, JULIE A. · 2005 to 2014
$20.7M
UF Clinical and Translational Science AwardUL1TR000064 · NCATS · UNIVERSITY OF FLORIDA · PI NELSON, DAVID R · 2012 to 2014
$12.2M
GENETIC EPIDEMIOLOGY OF RESPONSES TO ANTIHYPERTENSIVESR01HL053330 · NHLBI · MAYO CLINIC ROCHESTER · PI TURNER, STEPHEN T · 1997 to 2006
$5.5M
Anthipertensive PharmacoGenomicsR01HL074735 · NHLBI · MAYO CLINIC ROCHESTER · PI TURNER, STEPHEN T · 2003 to 2006
$3.4M
Metabolic Effects of Antihypertensive DrugsK23HL086558 · NHLBI · UNIVERSITY OF FLORIDA · PI COOPER-DEHOFF, RHONDA M · 2007 to 2011
$672k
British Heart Foundation CH/98001British Heart Foundation FS/05/095/19937British Heart Foundation FS/10/016/28162British Heart Foundation RG/07/005/23633British Heart Foundation SP/08/005/25115NCATS NIH HHS UL1 TR000064NCATS NIH HHS UL1 TR000135NCATS NIH HHS UL1 TR000454NHLBI NIH HHS HL053330NHLBI NIH HHS HL074735NHLBI NIH HHS HL086558NHLBI NIH HHS K23 HL086558NHLBI NIH HHS R01 HL053330NHLBI NIH HHS R01 HL074735NIGMS NIH HHS U01 GM074492
6 · The paper itself

Abstract

To identify novel genes influencing blood pressure response to thiazide diuretic therapy for hypertension, we conducted genome-wide association meta-analyses of ≈1.1 million single-nucleotide polymorphisms in a combined sample of 424 European Americans with primary hypertension treated with hydrochlorothiazide from the Pharmacogenomic Evaluation of Antihypertensive Responses study (n=228) and the Genetic Epidemiology of Responses to Antihypertensive study (n=196). Polymorphisms associated with blood pressure response at P<10(-5) were tested for replication of the associations in independent samples of hydrochlorothiazide-treated European hypertensives. The rs16960228 polymorphism in protein kinase C, α replicated for same-direction association with diastolic blood pressure response in the Nordic Diltiazem study (n=420) and the Genetics of Drug Responsiveness in Essential Hypertension study (n=206), and the combined 4-study meta-analysis P value achieved genome-wide significance (P=3.3 × 10(-8)). Systolic or diastolic blood pressure responses were consistently greater in carriers of the rs16960228 A allele than in GG homozygotes (>4/4 mm Hg) across study samples. The rs2273359 polymorphism in the GNAS-EDN3 region also replicated for same-direction association with systolic blood pressure response in the Nordic Diltiazem study, and the combined 3-study meta-analysis P value approached genome-wide significance (P=5.5 × 10(-8)). The findings document clinically important effects of genetic variation at novel loci on blood pressure response to a thiazide diuretic, which may be a basis for individualization of antihypertensive drug therapy and identification of new drug targets.

Indexed as

Genome-Wide Association StudyPolymorphism, Single NucleotideAdultAntihypertensive AgentsAtenololBlood PressureChromosomes, Human, Pair 17DiureticsFemaleHumansHydrochlorothiazideHypertensionMaleMiddle AgedProtein Kinase C-alphaTranscription FactorsAntihypertensive AgentsAtenololDiureticsHydrochlorothiazidenegative elongation factorPRKCA protein, humanProtein Kinase C-alphaTranscription Factorsantihypertensive agentsgenomicshydrochlorothiazidehypertensionpharmacogenomicsprotein kinase C

Identifiers

PMID23753411
PMCPMC3780966
OpenAlexW2127755983

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.